Evidence map›Paper›PMID 29996474›Full record

ReviewMarine drugs2018

Cardioprotective Effects of Omega-3 Polyunsaturated Fatty Acids: Dichotomy between Experimental and Clinical Studies.

Melissa Desnoyers, Kim Gilbert, Guy Rousseau

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Marine Natural Products and Coronary Artery Disease.Frontiers in cardiovascular medicine · 2021
    Review
  8. Review
  9. Article
  10. Lyme Disease Frontiers: ReconcilingPathogens (Basel, Switzerland) · 2019
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Melissa DesnoyersCentre de Biomédecine, Hôpital du Sacré-Cœur de Montréal, Montréal, QC H4J 1C5, Canada. melissa.desnoyers.1@umontreal.ca.
Kim GilbertCentre de Biomédecine, Hôpital du Sacré-Cœur de Montréal, Montréal, QC H4J 1C5, Canada. kim.gilbert3@gmail.com.
Guy RousseauCentre de Biomédecine, Hôpital du Sacré-Cœur de Montréal, Montréal, QC H4J 1C5, Canada. guy.rousseau@umontreal.ca.
Hôpital du Sacré-Cœur de Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high-fat diet of North Americans has a major impact on cardiovascular disease occurrence. Notably, fatty acids have been identified as important factors that could modulate such diseases, especially myocardial infarction (MI). Experimentally, omega-3 polyunsaturated fatty acids (PUFA) have demonstrated positive effects on cardiovascular disorders and have also shown cardioprotection by decreasing MI size. Although many animal experiments have clearly established the benefits of omega-3 PUFA, clinical studies have not reached similar conclusions. In fact, the findings of recent clinical investigations indicate that omega-3 PUFA play only a minor role in cardiovascular health. This dichotomy between experimental and clinical studies may be due to different parameters that are not taken into account in animal experiments. We have recently observed that the high consumption of omega-6 PUFA results in significant attenuation of the beneficial effect of omega-3 PUFA on MI. We believe that part of the dichotomy between experimental and clinical research may be related to the quantity of omega-6 PUFA ingested. This review of the data indicates the importance of considering omega-6 PUFA consumption in omega-3 PUFA studies.

Indexed as

Dietary SupplementsAnimalsCardiovascular DiseasesClinical Trials as TopicDisease Models, AnimalDrug InteractionsFatty Acids, Omega-3Fatty Acids, Omega-6HumansTreatment OutcomeFatty Acids, Omega-3Fatty Acids, Omega-6cardioprotectionmyocardial infarctionomega-3omega-6

Identifiers

PMID29996474
PMCPMC6071068
OpenAlexW2879083185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.